About the Prostate Cancer Screening Session
Prostate cancer screening is a critical aspect of cancer research, aimed at early detection and intervention for one of the most common cancers affecting men. Screening methods include the prostate-specific antigen (PSA) blood test and digital rectal exam (DRE). However, debate surrounds the effectiveness of routine screening due to concerns about overdiagnosis and overtreatment. While early detection can lead to timely treatment, it may also result in unnecessary interventions for slow-growing tumors. Researchers are exploring novel approaches like advanced imaging techniques and biomarker tests to improve screening accuracy and minimize harm. Personalized screening strategies based on individual risk factors are also gaining attention to optimize outcomes while reducing unnecessary procedures. Balancing the benefits and risks of prostate cancer screening remains a pivotal focus in cancer research to enhance early detection and treatment efficacy while minimizing adverse effects.
Topics Covered in Prostate Cancer Screening
PSA Testing
Digital Rectal Exam
Prebiopsy MRI
Blood & Urine Biomarkers
Overdiagnosis
Shared Decision Making
Related Scientific Sessions at CIOC 2027
Why Attend the Prostate Cancer Screening Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Prostate Cancer Screening work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Prostate Cancer Screening research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Prostate Cancer Screening track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Prostate Cancer Screening Conference 2027 — FAQs
What is the Prostate Cancer Screening track at CIOC 2027?
The Prostate Cancer Screening track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Prostate Cancer Screening. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Prostate Cancer Screening sessions?
Cancer researchers and clinicians, educators and students with an interest in Prostate Cancer Screening are all welcome — whether presenting or attending.
Can I present my research in the Prostate Cancer Screening track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Prostate Cancer Screening sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Prostate Cancer Screening track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.